Shawn Cort Kegley - Daily Journal dailyjournal.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyjournal.net Daily Mail and Mail on Sunday newspapers.
Breelyn A. Wilky, MD, discusses the rationale for investigating the combination of zalifrelimab, balstilimab, and doxorubicin in patients with advanced/metastatic soft tissue sarcoma, and early results from a phase 2 trial.
Treatment with doxorubicin plus zalifrelimab and balstilimab produced a favorable 6-month progression-free survival rate in patients with difficult-to-treat soft tissue sarcoma subtypes unlikely to respond to doxorubicin or immune checkpoint inhibitor monotherapy.